Integra LifeSciences Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Integra LifeSciences (IART) Tops Q3 EPS by 27c
October 28, 2020 6:13 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.80, $0.27 better than the analyst estimate of $0.53. Revenue for the quarter came in at $370.2 million versus the consensus estimate of $347.98 million.
The Company's full-year 2020 guidance remains withdrawn due to the uncertainty related to COVID-19 and... More